drugset / Trial / NCT00029822

Clinical Trial in Males With BPH (Enlarged Prostate)

NCT00029822

Phase 3 Completed 1522 enrolled Sanofi
RandomizedParallel-groupDouble-blindPrevention

Summary

A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH. * Free study-related medical care provided.

Timeline

Start
2001-05
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule 10 mg